Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Concord Medical Regains Compliance with NYSE Minimum Price Requirement
2024-08-07 20:30
Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States
2024-08-07 20:00
GSK's Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer
2024-08-07 09:00
Senhwa Biosciences receives US FDA Study May Proceed letter for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors
2024-08-07 08:49
Antimicrobial Materials Sector Surges Amid Hygiene and Health Revolution
2024-08-06 21:00
PHYLEX VACCINE ON TRACK TO COMBAT DEADLY NIPAH VIRUS WITH POSITIVE RESULTS OF IMMUNOGENICITY STUDY
2024-08-06 20:00
Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner
2024-08-06 19:00
Latest Updates of Viva Biotech's Portfolio Companies
2024-08-06 18:47
First patient enrollment in the U.S. - A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis
2024-08-06 17:00
First Patient Enrolled in the US Phase 2 Combination Therapy of Akeso's Ligufalimab with Azacitidine for Myelodysplastic Syndrome
2024-08-06 12:44
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics
2024-08-06 11:01
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia
2024-08-06 08:00
Everest Medicines to Announce 2024 Interim Results on August 28, 2024
2024-08-06 07:30
META Pharmaceuticals announces FDA Grants Rare Pediatric Disease Designation to META-001-PH for the Treatment of Primary Hyperoxaluria
2024-08-05 21:52
Shanton Reaches Full Enrollment in Phase 2b Refractory/Tophaceous Gout Study with SAP-001
2024-08-05 21:00
PENTAX Medical Receives FDA Clearance for Duodenoscope with New Sterilization Technology in Collaboration with Advanced Sterilization Products.
2024-08-05 20:00
Antennova Announces CD73 Small Molecule Inhibitor Accepted for Mini Oral Presentation at ESMO Congress 2024
2024-08-05 20:00
QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER
2024-08-05 19:00
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery
2024-08-05 16:30
DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific
2024-08-05 10:34
1
26
27
28
29
30
459